Innovent Biologics, Inc. carries a market capitalization of 18.91B, placing it among publicly traded companies globally.
| Market Cap | 18.91B |
| Enterprise Value | N/A |
Innovent Biologics, Inc.'s stock has declined approximately -8.7395% over the past 52 weeks. The 50-day moving average sits at 10.48, while the 200-day moving average is 10.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8.7395% |
| 50-Day Moving Average | 10.48 |
| 200-Day Moving Average | 10.82 |
| Average Volume (20 Days) | N/A |